Log in or Sign up for Free to view tailored content for your specialty!
Chronic Kidney Disease News
Q&A: Nephrologists’ perspectives matter in wearable dialysis device design
Insight from nephrologists and nephrology nurses on a wearable hemodialysis device will aid in refining its design, according to a presenter at the Innovations in Dialysis: Expediting Advances Symposium.
FDA grants approval of Terlivaz injection to treat patients with hepatorenal syndrome
The FDA has announced approval of Terlivaz, a terlipressin injection formulation by Mallinckrodt plc., to treat patients with hepatorenal syndrome with rapid reduction in kidney function.
Log in or Sign up for Free to view tailored content for your specialty!
More than half of patients report decisional conflict about kidney failure modalities
A high prevalence of patients with chronic kidney disease report decisional conflict about kidney failure treatment, regardless of their risk of kidney failure, according to data published in Kidney Medicine.
Conference chair: ‘Time of change’ for innovation, but new products for ESKD stay elusive
Five years of debate on advances in technology for treating kidney disease has not resulted in new products coming to market, but change is underway, the Innovations in Dialysis: Expediting Advances program chair said in recent remarks.
More prescriptions a patient has linked with poor nutritional status in those with CKD
Among patients with chronic kidney disease, the more medication prescriptions one has is associated with poor nutritional status, according to data published in the Journal of Renal Nutrition.
Researchers identify most studied biomarkers in the setting of CKD
Investigators identified tumor necrosis factor receptor 1 as the most frequently studied plasma biomarker in the setting of chronic kidney disease progression.
Dietary potassium intake linked with blood potassium concentration in patients with CKD
Among patients with advanced chronic kidney disease, increasing dietary potassium consumption to recommended levels can increase blood potassium concentration on a short-term basis, according to results of this study.
Urine to phosphate-to-creatinine ratio may predict adverse outcomes in people without CKD
Due to a significant association between the urine to phosphate-to-creatinine ratio and mortality among individuals without chronic kidney disease, researchers suggest this may be a predictor for future adverse events in this population.
Acute reduction in eGFR on dapagliflozin does not correlate with greater CKD progression
Among patients with chronic kidney disease and albuminuria treated with dapagliflozin, researchers did not identify a correlation between acute reduction in eGFR and higher rates of CKD progression.
Report cites health inequity, disconnect with primary care as barriers for treating CKD
A new report from the Milken Institute recommends that health officials prioritize identification of the root causes of health inequity that contribute to kidney disease in efforts to slow down its occurrence.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read